Pet Cancer Therapeutics industry analysis research and trends report for 2017-2024

1
Pet Cancer Therapeutics Market forecast to reach
300mn by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Pet Cancer Therapeutics Market

• Growing pet adoption rate coupled with increasing
  disposable income of pet owners will drive pet
  cancer therapeutics market growth. Strong and
  robust drug pipeline for treatment of pet cancer
  will stimulate business growth over the forecast
  years.
• High cost of pet cancer drugs along with rising
  instances of adverse drug events should hamper
  industry growth over the forecast years. Lack of
  awareness regarding pet diseases among the pet
  owners will impede industry expansion.
• Chemotherapy has been the mainstream medication
  for pet cancers till recent times.
• Dogs are more prone to develop cancer than cats
  and the healthy pipeline will drive segment
  growth over the forecast years. However,
  introduction of specialized cat cancer medicines
  will stimulate the cat cancer therapeutics market
  growth.
• Pet healthcare companies are focusing on
  development of drugs for mast cell cancer and
  melanoma among other cancer types.

3
Continued...

• This trend will witness change as medicines to
  treat lymphoma and mammary cell cancer are in the
  pipeline. Innovative medicines for treatment of
  multiple cancer tumors is anticipated to
  accelerate business growth.
• U.S. pet cancer therapeutics market holds the
  largest revenue share in 2016. Presence of large
  number of pet drug manufacturing companies, quick
  adoption of innovative pet care medicines and
  increasing disposable income of pet owners will
  boost industry growth.
• Australia pet cancer therapeutics market held
  highest regional revenue share in 2016 owing to
  growing pet-keeping trend, availability of
  innovative pet care medicines and increasing
  disposable income of pet owners.
• Some of the leading industry players include
  Zoetis, Merial, Aratana Therapeutics, AB Science,
  Vetivax, Oasmia Pharmaceutical, VetDC, Regeneus,
  CanFel Therapeutics, Karyopharms Verdinexor.
• The most commonly adopted business strategies by
  industry participants includes new product
  launches, regional expansion and mergers and
  acquisition.

4
U.S Pet cancer therapeutics market, by medicine
type, 2013 - 2024 (USD Million)

5

Browse Full Market Research Report On Pet
Cancer Therapeutics Market _at_ http//bit.ly/2fxZquX
Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/2017 https//www.gminsights.com/request-s
ample/detail/49
6
Stay In Touch Website www.gminsights.com Soci
al Media